SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-007863
Filing Date
2020-06-29
Accepted
2020-06-29 19:05:10
Documents
69
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hepa-20200331x10q.htm 10-Q 923191
2 EX-31.1 hepa-20200331ex311e1fe07.htm EX-31.1 10843
3 EX-31.2 hepa-20200331ex312ee6556.htm EX-31.2 10029
4 EX-32.1 hepa-20200331ex3219c435d.htm EX-32.1 5844
5 EX-32.2 hepa-20200331ex3226a97d7.htm EX-32.2 5529
6 GRAPHIC hepa-20200331x10q002.jpg GRAPHIC 4347
  Complete submission text file 0001558370-20-007863.txt   5320062

Data Files

Seq Description Document Type Size
7 EX-101.INS hepa-20200331.xml EX-101.INS 1206699
8 EX-101.SCH hepa-20200331.xsd EX-101.SCH 45161
9 EX-101.CAL hepa-20200331_cal.xml EX-101.CAL 35264
10 EX-101.DEF hepa-20200331_def.xml EX-101.DEF 176745
11 EX-101.LAB hepa-20200331_lab.xml EX-101.LAB 407725
12 EX-101.PRE hepa-20200331_pre.xml EX-101.PRE 322350
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 20998820
SIC: 2834 Pharmaceutical Preparations